MZC microbicide gel outperforms Tenofovir 1% gel in preclinical evaluation of microbicide candidates
New data from a preclinical safety and efficacy study of the candidate microbicide gel MZC, which targets HIV, herpes simplex virus (HSV-2) and human papillomavirus (HPV), shows that the gel performs as well as, or in many ...
Nov 25, 2015
0
2